Effectiveness of an NK1 Antagonist in PTSD.
Latest Information Update: 14 Mar 2013
At a glance
- Drugs Vofopitant (Primary)
- Indications Post-traumatic stress disorders
- Focus Biomarker; Therapeutic Use
- 11 Mar 2013 Additional lead trial centre added as reported by ClinicalTrials.gov record.
- 14 Apr 2009 Planned number of patients changed from 52 to 47, additional lead trial centre identified, actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.